INM
Price
$3.38
Change
-$0.08 (-2.31%)
Updated
Jun 27 closing price
Capitalization
4.13M
XFOR
Price
$1.83
Change
-$0.17 (-8.50%)
Updated
Jun 27 closing price
Capitalization
13.14M
32 days until earnings call
Interact to see
Advertisement

INM vs XFOR

Header iconINM vs XFOR Comparison
Open Charts INM vs XFORBanner chart's image
InMed Pharmaceuticals
Price$3.38
Change-$0.08 (-2.31%)
Volume$257.8K
Capitalization4.13M
X4 Pharmaceuticals
Price$1.83
Change-$0.17 (-8.50%)
Volume$966.5K
Capitalization13.14M
INM vs XFOR Comparison Chart in %
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. XFOR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a Hold and XFOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (INM: $3.38 vs. XFOR: $1.83)
Brand notoriety: INM and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 6% vs. XFOR: 339%
Market capitalization -- INM: $4.13M vs. XFOR: $13.14M
INM [@Biotechnology] is valued at $4.13M. XFOR’s [@Biotechnology] market capitalization is $13.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 2 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 2 green, 3 red.
According to our system of comparison, both INM and XFOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 6 TA indicator(s) are bullish while XFOR’s TA Score has 3 bullish TA indicator(s).

  • INM’s TA Score: 6 bullish, 3 bearish.
  • XFOR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, INM is a better buy in the short-term than XFOR.

Price Growth

INM (@Biotechnology) experienced а +35.74% price change this week, while XFOR (@Biotechnology) price change was -31.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

XFOR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XFOR($13.1M) has a higher market cap than INM($4.13M). XFOR has higher P/E ratio than INM: XFOR (0.87) vs INM (0.01). INM YTD gains are higher at: -26.362 vs. XFOR (-91.685). XFOR has higher annual earnings (EBITDA): 25.2M vs. INM (-7.86M). XFOR has more cash in the bank: 87M vs. INM (4.68M). INM has less debt than XFOR: INM (849K) vs XFOR (78M). XFOR has higher revenues than INM: XFOR (31.4M) vs INM (4.92M).
INMXFORINM / XFOR
Capitalization4.13M13.1M32%
EBITDA-7.86M25.2M-31%
Gain YTD-26.362-91.68529%
P/E Ratio0.010.872%
Revenue4.92M31.4M16%
Total Cash4.68M87M5%
Total Debt849K78M1%
FUNDAMENTALS RATINGS
INM vs XFOR: Fundamental Ratings
INM
XFOR
OUTLOOK RATING
1..100
9951
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9812
PRICE GROWTH RATING
1..100
4198
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XFOR's Valuation (17) in the Biotechnology industry is in the same range as INM (40) in the null industry. This means that XFOR’s stock grew similarly to INM’s over the last 12 months.

XFOR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INM (100) in the null industry. This means that XFOR’s stock grew similarly to INM’s over the last 12 months.

XFOR's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for INM (98) in the null industry. This means that XFOR’s stock grew significantly faster than INM’s over the last 12 months.

INM's Price Growth Rating (41) in the null industry is somewhat better than the same rating for XFOR (98) in the Biotechnology industry. This means that INM’s stock grew somewhat faster than XFOR’s over the last 12 months.

INM's P/E Growth Rating (82) in the null industry is in the same range as XFOR (100) in the Biotechnology industry. This means that INM’s stock grew similarly to XFOR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMXFOR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPK97.920.61
+0.63%
National Presto Industries
QDEL28.870.17
+0.59%
QuidelOrtho Corp
BHR2.60-0.05
-1.89%
Braemar Hotels & Resorts
EC8.93-0.31
-3.35%
Ecopetrol SA
NXTT2.04-0.16
-7.27%
Next Technology Holding

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with OMER. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then OMER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-2.31%
OMER - INM
46%
Loosely correlated
-3.61%
TTNP - INM
43%
Loosely correlated
-1.79%
SPHDF - INM
33%
Poorly correlated
N/A
XFOR - INM
32%
Poorly correlated
-8.50%
SQZB - INM
29%
Poorly correlated
N/A
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with ABP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then ABP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-8.50%
ABP - XFOR
50%
Loosely correlated
-5.38%
HOFBF - XFOR
35%
Loosely correlated
N/A
CRDF - XFOR
32%
Poorly correlated
-0.32%
INM - XFOR
32%
Poorly correlated
-2.31%
ABSI - XFOR
31%
Poorly correlated
-3.32%
More